Adsorption of cisplatin by the surface of the magnetic sensitive nanocomposite FeO/AlO/С
Himia, Fizika ta Tehnologia Poverhni, ISSN: 2518-1238, Vol: 12, Issue: 4, Page: 291-300
2021
- 1Citations
- 3Captures
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Article Description
One of the most widely used antitumor chemotherapeutic drugs is “Cisplatin” (active substance - cisdiaminodichloroplatinum), the side effects of which are the cumulative ototoxic, nephrotoxic and neurotoxic effects. The use of drug carrier systems for targeted delivery and adsorbents for extraction, in particular magnetite-carbon nanocomposites, will minimize unwanted toxic effects without reducing the therapeutic effect of cisplatin. For this purpose, a nanocomposite (NCs) of FeO/AlO/С with a carbon surface was synthesized, where a layer of alumina protects magnetite during the pyrolysis of carbohydrates. The synthesized samples were characterized by TEM, XRD, mass spectrometry methods, magnetic properties and specific surface area were studied. It has been found that the used heat treatment mode (T = 500 °С, argon medium) is sufficient for complete carbonization of sucrose and preserves the phase of magnetite which does not lead to deterioration of magnetic characteristics. The results of TEM studies and magnetic measurements indicate the formation of the FeO/AlO/С nanocomposite of the core-shell type. The adsorption of Cisplatin on the surface of NCs FeO/AlO/С was performed and the adsorption process dependent on the contact time, pH of the solution and cisplatin concentration was studied. The experimental results of kinetic studies were analyzed for compliance with the theoretical models of Boyd and Morris-Weber, models of pseudo-first and pseudo-second orders. Langmuir and Freundlich isotherm models were used to model adsorption processes. The limiting factor of adsorption is the external diffusion mass transfer processes, which correlates with the calculated parameters of the pseudo-first-order model (r = 0.985). The correlation of theoretical and practically obtained values of adsorption capacity indicates the possibility of using the Freundlich model to describe the adsorption of Cisplatin on the surface of FeO/AlO/C.
Bibliographic Details
National Academy of Sciences of Ukraine (Co. LTD Ukrinformnauka) (Publications)
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know